Malignant and pseudomalignant hyperplasia adenomatosa of the endometrium in postmenopausal women treated with oestrogen.
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D000368:Aged; D000728:Androgens; D002979:Climacteric; D003475:Curettage; D003937:Diagnosis, Differential; D004714:Endometrial Hyperplasia / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D004717:Endometrium / Q000494:pharmacology*; D004952:Esters; D004958:Estradiol / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008796:Metrorrhagia / Q000139:chemically induced; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy
D000728:Androgens; D004952:Esters; D004967:Estrogens; D004958:Estradiol